Clinical Trials Browser

Recruiting × Glioblastoma × Carmustine × Clear all

NCT05052957 2025-11-21

hSTAR GBM

Phase 2 Recruiting

Glioblastoma

NCT03382977 2025-03-11

Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

Phase 1/2 Recruiting

Glioblastoma, Neoplasms